The immune system plays a key role in the development and progression of cutaneous squamous cell carcinoma (cSCC), and immune checkpoint inhibitors are a key treatment for advanced disease. In this interactive video lecture, a skin cancer specialist discusses the signs and symptoms of advanced cSCC, provides guidance and supporting evidence for immunotherapies in this disease, and shares best practices to identify and manage immune-related adverse events.
Interactive video lecture
After completing this activity, participants should be better able to:
- Identify signs and symptoms of advanced cSCC
- Formulate treatment strategies for use of immune checkpoint inhibitors in advanced cSCC based on guideline recommendations and efficacy and safety data
- Apply strategies to identify and manage immune-related adverse events in patients on immune checkpoint inhibitor therapy for cSCC
Oncology NPs, PAs, and nurses
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until July 29, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Jessica Garner, DMSc, PA-C, University of the Pacific, Sacramento, California
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi Genzyme.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Khushalani: consulting fees: Array BioPharma, AstraZeneca, Bristol Myers Squibb, Genzyme, Immunocore, Incyte, Iovance Biotherapeutics, Jounce Therapeutics, Merck, NCCN/Pfizer, Regeneron; contracted research (paid to institution): Amgen, Bristol Myers Squibb, Celgene, GlaxoSmithKline, Huya Biosciences, Merck, Novartis, Regeneron, Replimune; ownership interest: Amarin Corporation, Asensus Surgical, Bellicum Pharmaceuticals, Mazor Robotics; other financial or material support: Sanofi.
Ms Madden: consulting fees: Novartis.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hours.
Release date: July 30, 2021
Expiration date: July 29, 2022
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 100721O-7A